Publication in Diabetologia highlights AI's potential for Type 1 Diabetes screening

The article is the result of a conference organized in Malmö in May 2022 by the ASSET consortium (www.asset.healthcare) where key factors and opportunities around the integration of Artificial Intelligence (AI) in early Type 1 Diabetes screening were discussed. The publication highlights the need for precision in risk assessment and individualized monitoring plans. The article also highlights the overall feasibility and cost-effectiveness of screening. The ASSET consortium is financed by the Swedish innovation agency VINNOVA and coordinated by Diamyd Medical.“With Diamyd Medical’s